Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability.
Corr BR, Thomas SM, Haight PJ, Stock E, Floyd J, Borden LE, Tunnage I, Secord AA, Arend R, Jackson AL, Wright JD, Konecny G, Castellano T, Ko E, Podwika S, Backes F, Spinosa D, Mullen M, Washington C, Pothuri B, Smitherman C, Harsono AAH, Khadraoui H, Suzuki Y, Salani R, Powell K, Subbarao S, Gaillard S.
Corr BR, et al. Among authors: spinosa d.
Gynecol Oncol. 2025 Oct;201:69-75. doi: 10.1016/j.ygyno.2025.08.008. Epub 2025 Aug 14.
Gynecol Oncol. 2025.
PMID: 40816031